These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 24292552)

  • 21. Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy.
    Masemann D; Boergeling Y; Ludwig S
    Biol Chem; 2017 Jul; 398(8):891-909. PubMed ID: 28441138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic virotherapy.
    Russell SJ; Peng KW; Bell JC
    Nat Biotechnol; 2012 Jul; 30(7):658-70. PubMed ID: 22781695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of oncolytic adenovirus and its application in cancer therapy.
    Liang Y; He J; Zhao Y
    Discov Med; 2020; 30(161):129-144. PubMed ID: 33593481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent clinical experience with oncolytic viruses.
    Donnelly OG; Errington-Mais F; Prestwich R; Harrington K; Pandha H; Vile R; Melcher AA
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1834-41. PubMed ID: 21740364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model.
    Uche IK; Fowlkes N; Vu L; Watanabe T; Carossino M; Nabi R; Del Piero F; Rudd JS; Kousoulas KG; Rider PJF
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncolytic virus therapy for cancer: the first wave of translational clinical trials.
    Patel MR; Kratzke RA
    Transl Res; 2013 Apr; 161(4):355-64. PubMed ID: 23313629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.
    Breitbach CJ; Thorne SH; Bell JC; Kirn DH
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.
    Kaur B; Chiocca EA; Cripe TP
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1842-51. PubMed ID: 21740359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T
    Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oncolytic viruses as a new way of treatment of neoplastic diseases].
    Kukla U; Chronowska J; Łabuzek K; Okopień B
    Pol Merkur Lekarski; 2015 Aug; 39(230):116-21. PubMed ID: 26319388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic virotherapy for urological cancers.
    Delwar Z; Zhang K; Rennie PS; Jia W
    Nat Rev Urol; 2016 Jun; 13(6):334-52. PubMed ID: 27215429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncolytic viruses: what to expect from their use in cancer treatment.
    Terrível M; Gromicho C; Matos AM
    Microbiol Immunol; 2020 Jul; 64(7):477-492. PubMed ID: 31663631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic Viruses in Cancer Treatment: A Review.
    Lawler SE; Speranza MC; Cho CF; Chiocca EA
    JAMA Oncol; 2017 Jun; 3(6):841-849. PubMed ID: 27441411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic viruses targeting tumor stem cells.
    Chiocca EA; Blair D; Mufson RA
    Cancer Res; 2014 Jul; 74(13):3396-8. PubMed ID: 24753541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
    Turnbull S; West EJ; Scott KJ; Appleton E; Melcher A; Ralph C
    Viruses; 2015 Dec; 7(12):6291-312. PubMed ID: 26633468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering and combining oncolytic measles virus for cancer therapy.
    Leber MF; Neault S; Jirovec E; Barkley R; Said A; Bell JC; Ungerechts G
    Cytokine Growth Factor Rev; 2020 Dec; 56():39-48. PubMed ID: 32718830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of viruses in the treatment of solid tumours.
    Bourke MG; Salwa S; Harrington KJ; Kucharczyk MJ; Forde PF; de Kruijf M; Soden D; Tangney M; Collins JK; O'Sullivan GC
    Cancer Treat Rev; 2011 Dec; 37(8):618-32. PubMed ID: 21232872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.